#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Mucopolysaccharidosis II Hepatocellular carcinoma Human papilloma virus immunisation Chronic granulomatous disease Ichthyosis Severe myoclonic epilepsy of infancy Leukocyte adhesion deficiency type I Fibrous dysplasia of bone Nasopharyngeal cancer Isodicentric chromosome 15 syndrome Candida infection Adrenoleukodystrophy Chronic lymphocytic leukaemia Antiphospholipid antibodies More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Treatment Hairy cell leukaemia – Life with Disease Mastocytosis – Treatment Systemic sclerosis pulmonary – Basic Information Combined immunodeficiency – Life with Disease Netherton’s syndrome – Life with Disease Leiomyosarcoma recurrent – Basic Information Progressive supranuclear palsy – Life with Disease Burkitt’s lymphoma – Life with Disease Pleural mesothelioma malignant – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Insulin Aspart Dexketoprofen Zoledronic Acid Monohydrate Midodrine Hydrochloride GOLD SODIUM THIOSULFATE Lutetium (177Lu)-Neobomb1 Blu-263 Phosphate Indapamide AZD0516 Cinnarizine Bidridistrogene Xeboparvovec Golimumab L-Threonine BIIB115 Zinc Acetate Dihydrate Adenosine Phenazone Sunvozertinib Pd01B Histamine Hydrochloride More therapies…

    Learn about Your Condition

    Frostbite Perthes disease Perinatal depression Catatonia Complex regional pain syndrome Amyloidosis Urticaria cholinergic Radiation skin injury Dystonia Small cell carcinoma Medulloblastoma Impaired gastric emptying Corneal graft failure Pelvic venous thrombosis Nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

    Not recruiting

    3 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Austria Belgium Czechia France Germany Greece +6

  • Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    • Penile squamous cell carcinoma
    • Squamous cell carcinoma of the cervix
    Investigated Drugs:
    • Vorinostat
    • Pembrolizumab
    France

  • Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Palbociclib
    • Anastrozole
    • Cyclophosphamide
    Belgium France Germany Italy Poland Portugal +1

  • Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Db-1303
    • Capecitabine
    • Paclitaxel
    Belgium France Germany Hungary Italy Poland +1

  • Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Gemcitabine
    Czechia Denmark France Germany Greece Italy +5

  • Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Palbociclib
    • Anastrozole
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Papillary serous endometrial carcinoma
    Investigated Drugs:
    • Aprepitant
    • Azenosertib
    • Granisetron
    France Italy Spain

  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Abiraterone
    • Degarelix
    • Relugolix
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Disodium Folinate
    • Bevacizumab
    • Fluorouracil
    Austria Belgium Czechia Denmark France Germany +6
Previous Page
1 … 19 20 21 22 23 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!